Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Dan C. Henry"'
Publikováno v:
Clinical Therapeutics. 26:2026-2033
Background: Treatment guidelines for acute bacterial rhinosinusitis (ABRS) recommend 10 to 14 days of therapy with high-dose amoxicillin, amoxicillin/clavulanate, cefdinir, cefpodoxime, cefuroxime, a macrolide, or a newer fluoroquinolone, among other
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8aec53de2c8df4fc4a4ebf571e8f50c
https://doi.org/10.1016/j.clinthera.2004.12.004
https://doi.org/10.1016/j.clinthera.2004.12.004
Autor:
G. Michael Wall, Dan C. Henry, Susan L. Potts, Sheryl J. Dupre, L. Gail Hogg, Peter S. Roland, Francis D. Pien, Rekha Garadi, David W. Stroman, Craig C. Schultz, Peter J. Conroy
Publikováno v:
Current Medical Research and Opinion. 20:1175-1183
To compare the efficacy and safety of ciprofloxacin 0.3%/dexamethasone 0.1% (CIP/DEX) otic suspension with that of neomycin 0.35%/polymyxin B 10,000 IU/mL/hydrocortisone 1.0% (N/P/H) otic suspension in patients with acute otitis externa (AOE).Randomi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::612187495cde1cd46ef2ad867403185e
https://doi.org/10.1185/030079902125004312
https://doi.org/10.1185/030079902125004312
Publikováno v:
Antimicrobial Agents and Chemotherapy. 47:2770-2774
A randomized, double-blind, multicenter study of adults with acute bacterial sinusitis (ABS) compared the efficacy and safety of two azithromycin (AZM) regimens, 500 mg/day once daily for 3 days (AZM-3) or 6 days (AZM-6) to the efficacy and safety of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c09f7685c58edacff5541b10fbe81572
https://doi.org/10.1128/aac.47.9.2770-2774.2003
https://doi.org/10.1128/aac.47.9.2770-2774.2003
Autor:
Steven F. Kowalsky, Robert B. Bettis, Deborah A. Church, Kathryn Manning, Kamal Hamed, Ernie Riffer, Daniel Haverstock, Dan C. Henry
Publikováno v:
Clinical Therapeutics. 24:2088-2104
Background: Trimethoprim/sulfamethoxazole (TMP/SMX) is currently the first choice for empiric therapy of acute uncomplicated urinary tract infection (UTI) in women. In areas where resistance to TMP/SMX is known to be high, ciprofloxacin and other flu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9364795f61db3e5ed5e27bf0e1e9bef
https://doi.org/10.1016/s0149-2918(02)80099-6
https://doi.org/10.1016/s0149-2918(02)80099-6
Autor:
W.M. Gooch, Kenneth J. Tack, James M. McCarty, Dan C. Henry, Constance H. Keyserling, Mary Anne Nemeth
Publikováno v:
Clinical Therapeutics. 21:1873-1881
Cefdinir, an oral cephalosporin active against Streptococcus pyogenes (group A beta-hemolytic streptococci [GABHS]), is also resistant to degradation by most oropharyngeal beta-lactamases. This multicenter, randomized, controlled, double-masked study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53ae814c23d7e36389fafbdfd921824c
https://doi.org/10.1016/s0149-2918(00)86735-1
https://doi.org/10.1016/s0149-2918(00)86735-1
Autor:
Mary Beth Dorr, Robert C. Nenad, George H. Talbot, Alan D. Tice, Dan C. Henry, David Magner, Debra L. Mansfield, Abdollah Iravani
Publikováno v:
Clinical Therapeutics. 21:966-981
Urinary tract infection (UTI) is a common illness, with ≥30% of all women experiencing a UTI during their lifetime. Less than a decade ago, the standard therapy for acute uncomplicated UTIs involved treatment with ≥7 days of an antibacterial agen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c9d79d92ec63f3cf1d36036c7639bac
https://doi.org/10.1016/s0149-2918(99)80018-6
https://doi.org/10.1016/s0149-2918(99)80018-6
Autor:
Thomas Nolan, Robert Schwartz, Bruce Miller, Benjamin A. Lipsky, George H. Talbot, David Magner, Ann McCabe, Dan C. Henry
Publikováno v:
Clinical Therapeutics. 21:675-690
Fluoroquinolones have been shown to be effective in the treatment of complicated skin and skin-structure infections, in part because of their broad-spectrum antibacterial activity against causative pathogens that are resistant to older antimicrobial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8ad3fe8dcd837d38f18b9a8e6879baf
https://doi.org/10.1016/s0149-2918(00)88319-8
https://doi.org/10.1016/s0149-2918(00)88319-8
Autor:
W. Michael Scheid, George H. Talbot, Dan C. Henry, Daniel J. Moller, Hao Zhang, Jeffrey Adelglass, Carol K. Jablonski
Publikováno v:
Clinical Therapeutics. 21:340-352
Five hundred four patients were enrolled in a randomized, double-masked, multicenter study comparing the efficacy and tolerability of a 10-day regimen of sparfloxacin with a 14-day regimen of clarithromycin in the treatment of acute maxillary sinusit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ddcf21f2fe0da6cfa82351764f977e6
https://doi.org/10.1016/s0149-2918(00)88291-0
https://doi.org/10.1016/s0149-2918(00)88291-0
Autor:
Gregory Giguere, Grace Lecara, Douglas Myers, Dan C. Henry, C. Andrew DeAbate, John Upchurch, Jeffrey J. Collins
Publikováno v:
Clinical Drug Investigation. 17:21-31
Objectives: The clinical and bacteriological efficacies and tolerability of grepafloxacin 400mg once daily for 10 days were compared with clarithromycin 500mg twice daily for 10 days in patients with acute bacterial exacerbations of chronic bronchiti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6323032ba9fcf168f4d41d0c689d1a4d
https://doi.org/10.2165/00044011-199917010-00003
https://doi.org/10.2165/00044011-199917010-00003
Autor:
Scott Burroughs, H. Preston Holley, C. Andrew DeAbate, Robert Bettis, Anthony Puopolo, Dan C. Henry, Margaret M. Cobb, Gary E. Ruoff, Michael Noonan
Publikováno v:
Clinical Drug Investigation. 18:335-344
Objective and Study Design: This multicentre, randomised, double-blind clinical trial compared the clinical and bacteriological efficacy and safety of cefuroxime axetil and amoxicillin/clavulanic acid in the treatment of secondary bacterial infection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69f1ce0dda110c65858a3fe64f612054
https://doi.org/10.2165/00044011-199918050-00001
https://doi.org/10.2165/00044011-199918050-00001